van den Hoogen FHJ - Search Results

1

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial.

Mulder MLM, Vriezekolk JE, van Hal TW, Nieboer LM, den Broeder N, de Jong EMGJ, den Broeder AA, van den Hoogen FHJ, Helliwell PS, Wenink MH. Mulder MLM, et al. Among authors: van den hoogen fhj. Lancet Rheumatol. 2022 Apr;4(4):e252-e261. doi: 10.1016/S2665-9913(22)00028-5. Epub 2022 Feb 28. Lancet Rheumatol. 2022. PMID: 38288921

2

Clinical aspects of systemic and localized scleroderma.

van den Hoogen FH, de Jong EM. van den Hoogen FH, et al. Curr Opin Rheumatol. 1995 Nov;7(6):546-50. doi: 10.1097/00002281-199511000-00014. Curr Opin Rheumatol. 1995. PMID: 8579977 Review.

3

Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.

van den Hoogen FH, Boerbooms AM, Swaak AJ, Rasker JJ, van Lier HJ, van de Putte LB. van den Hoogen FH, et al. Br J Rheumatol. 1996 Apr;35(4):364-72. doi: 10.1093/rheumatology/35.4.364. Br J Rheumatol. 1996. PMID: 8624641 Free article. Clinical Trial.

4

Reliability of two methods to assess morphea: skin scoring and the use of a durometer.

Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Seyger MM, et al. J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):793-6. doi: 10.1016/s0190-9622(97)70121-x. J Am Acad Dermatol. 1997. PMID: 9366834 Free article. Clinical Trial. No abstract available.

5

Low-dose methotrexate in the treatment of widespread morphea.

Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Seyger MM, et al. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):220-5. doi: 10.1016/s0190-9622(98)70079-9. J Am Acad Dermatol. 1998. PMID: 9704833 Clinical Trial.

6

Postural changes, dysphagia, and systemic sclerosis.

Barrera P, den Broeder AA, van den Hoogen FH, van Engelen BG, van de Putte LB. Barrera P, et al. Ann Rheum Dis. 1998 Jun;57(6):331-8. doi: 10.1136/ard.57.6.331. Ann Rheum Dis. 1998. PMID: 9771206 Free PMC article. No abstract available.

7

Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosus.

Seyger MM, van Bruggen MC, Hardeman HK, van den Hoogen FH, Berden JH, van den Born J, De Jong EM. Seyger MM, et al. Acta Derm Venereol. 1998 Sep;78(5):326-30. doi: 10.1080/000155598442971. Acta Derm Venereol. 1998. PMID: 9779246 Free article.

8

Systemic sclerosis: new insights in autoimmunity.

Kaal SE, van Den Hoogen FH, de Jong EM, Viëtor HE. Kaal SE, et al. Proc Soc Exp Biol Med. 1999 Oct;222(1):1-8. doi: 10.1111/j.1525-1373.1999.09991.x. Proc Soc Exp Biol Med. 1999. PMID: 10510242 Review.

9

Localized and systemic scleroderma show different histological responses to methotrexate therapy.

Seyger MM, van den Hoogen FH, van Vlijmen-Willems IM, van de Kerkhof PC, de Jong EM. Seyger MM, et al. J Pathol. 2001 Apr;193(4):511-6. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH779>3.0.CO;2-8. J Pathol. 2001. PMID: 11276011

10

Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatment.

den Broeder AA, van den Hoogen FH, van de Putte LB. den Broeder AA, et al. Ann Rheum Dis. 2001 May;60(5):538-9. doi: 10.1136/ard.60.5.538. Ann Rheum Dis. 2001. PMID: 11302883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters